# Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

> **NCT00448396** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 17 (actual)

## Conditions studied

- Advanced Malignancies

## Interventions

- **DRUG:** Patupilone

## Key facts

- **NCT ID:** NCT00448396
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-02
- **Final completion:** —
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2009-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448396, "Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00448396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*